Convulsive therapies induce a variety of opinions in professional and public audiences. However, they provide much benefit to treatment-resistant patients in a range of disorders. The development of magnetic seizure therapy has come out of the desire to provide a convulsive treatment that has the efficacy of electroconvulsive therapy without its cognitive side effects.
• Identify the current indications for electroconvulsive therapy (ECT) in psychiatry.
• Understand the differences between ECT and magnetic seizure therapy.
• Relate the advantages of magnetic seizure therapy over ECT and how this impacts patient populations.
Primary care physicians and psychiatrists.
Mount Sinai School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Mount Sinai School of Medicine designates this educational activity for a maximum of 3.0 Category 1 credit(s) toward the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the educational activity. Credits will be calculated by the MSSM OCME and provided for the journal upon completion of agenda.
It is the policy of Mount Sinai School of Medicine to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored activities. All faculty participating in sponsored activities are expected to disclose to the audience any real or apparent conflict-of-interest related to the content of their presentation, and any discussion of unlabeled or investigational use of any commercial product or device not yet approved in the United States.
To receive credit for this activity:
Read this article and the two CME-designated accompanying articles, reflect on the information presented, and then complete the CME quiz. To obtain credits, you should score 70% or better. Termination date: October 31, 2007. The estimated time to complete all three articles and the quiz is 3 hours.
Primary Psychiatry. 2005;12(10):44-50